Hemab Therapeutics (COAG) AI Analysis
COAG$40.86+1.48 +3.76%
Market cap$1.91BEnterprise value$1.39BRevenue (TTM)$0Market position—
Score
70
Bullish
Value
66
Quality
50
Growth
95
Hemab Therapeutics Holdings, Inc. Common Stock is a growth-led story right now — Growth 95/100 is the pillar doing the heavy lifting (overall 70/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~26% upside.